Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

The valuation ratios exhibit varied trends over the observed period, spanning from March 31, 2022, to December 31, 2025. Generally, the ratios demonstrate increasing values through much of 2022 and into early 2023, followed by fluctuations and, in some cases, a decline towards the end of the period. These shifts suggest evolving investor sentiment and potentially changing perceptions of the company’s future earnings potential and asset valuation.

Price to Earnings (P/E) Ratio

The P/E ratio increased consistently from 9.15 in March 2022 to 25.99 in December 2022, indicating growing investor confidence in earnings. This upward trend continued into early 2023, peaking at 19.77 in March 2023. Subsequently, the ratio experienced volatility, decreasing to 13.65 by March 2025 before rising again to 18.19 by December 2025. This suggests a period of reassessment followed by renewed, though not fully restored, optimism regarding earnings.

Price to Operating Profit (P/OP) Ratio

Similar to the P/E ratio, the P/OP ratio showed a clear upward trajectory through 2022, rising from 7.98 to 25.39. The ratio mirrored the P/E trend, peaking in early 2023 at 18.68 and 19.32, then exhibiting fluctuations. A decline to 16.03 was observed in March 2025, followed by an increase to 22.90 by the end of the period. The correlation with the P/E ratio suggests that changes in operating profitability are a key driver of valuation.

Price to Sales (P/S) Ratio

The P/S ratio demonstrated a steady increase from 4.40 in March 2022 to 7.84 in December 2022, indicating investors were willing to pay more for each dollar of revenue. This trend continued into mid-2023, reaching 6.61 in June 2023. The ratio then experienced a more pronounced decline, reaching a low of 4.17 in June 2025, before recovering to 5.71 by December 2025. This suggests a potential shift in investor focus from revenue growth to profitability or other valuation metrics.

Price to Book Value (P/BV) Ratio

The P/BV ratio exhibited less dramatic fluctuations compared to the other ratios. It began at 3.65 in March 2022, with moderate changes throughout 2022 and 2023. A noticeable decline was observed from March 2024, reaching a low of 1.98 in June 2025, before recovering slightly to 2.62 by December 2025. This decrease may indicate a reassessment of the company’s asset value relative to its market price, potentially reflecting concerns about asset utilization or future returns.

Overall, the observed trends suggest a period of increasing valuation through 2022, followed by a period of reassessment and volatility. The declines in P/S and P/BV ratios, particularly in 2024 and early 2025, warrant further investigation to understand the underlying factors influencing investor perception of the company’s value.

The price-to-earnings (P/E) ratio exhibited a generally increasing trend over the observed period, punctuated by periods of decline. Initial values indicated a relatively low valuation, which subsequently expanded before experiencing a recent contraction.

Initial Phase (Mar 31, 2022 – Dec 31, 2022)

The P/E ratio began at 9.15 and demonstrated a consistent upward trajectory, reaching 19.68 by the end of December 2022. This suggests increasing investor confidence or expectations regarding future earnings growth during this timeframe. The increase indicates investors were willing to pay more for each dollar of earnings.

Stabilization and Subsequent Increase (Mar 31, 2023 – Sep 30, 2023)

Following the initial increase, the P/E ratio stabilized around the 19 to 22 range for several quarters. A further increase was observed, peaking at 25.99 in December 2023, continuing the trend of expanding valuation. This period suggests sustained positive sentiment.

Recent Contraction (Mar 31, 2024 – Dec 31, 2025)

A notable decline in the P/E ratio commenced in March 2024, falling from 26.78 to a low of 13.29 by June 2025. While some recovery occurred, with the ratio reaching 18.19 by December 2025, the overall trend indicates a significant contraction in valuation. This could be attributed to factors such as decreased investor confidence, concerns about future earnings, or a correction following the prior period of expansion. The decrease suggests investors are paying less for each dollar of earnings.

The fluctuations in the P/E ratio appear to be influenced by both changes in share price and earnings per share. While earnings per share remained relatively stable throughout the period, the share price experienced more significant volatility, contributing to the observed changes in the P/E ratio. The most recent period demonstrates a more pronounced decrease in the P/E ratio, potentially signaling a shift in market perception.

Earnings Per Share (EPS) Influence

Earnings per share exhibited a gradual decline from 72.22 in March 2022 to approximately 42.61 in December 2025. However, the P/E ratio’s movements were not directly proportional to EPS changes, indicating that share price fluctuations played a more dominant role in the ratio’s overall trend.

In summary, the P/E ratio experienced a period of expansion followed by a recent contraction. The observed trends suggest a dynamic valuation influenced by both market sentiment and underlying earnings performance.

The Price to Operating Profit (P/OP) ratio for the analyzed period demonstrates a generally increasing trend, punctuated by periods of fluctuation. Initially, the ratio exhibited volatility, followed by a sustained increase, and then a more recent decline. This suggests shifts in investor sentiment and potentially evolving expectations regarding the company’s profitability.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The P/OP ratio began at 7.98 and experienced considerable fluctuation, reaching a peak of 18.01 by the end of December 2022. This initial increase suggests growing investor confidence in the company’s operating performance during this timeframe. The ratio more than doubled over this period.

Sustained High Values (Mar 31, 2023 – Dec 31, 2023)

From March 2023 through December 2023, the P/OP ratio remained at elevated levels, continuing to climb to a high of 25.39. This indicates continued positive market perception of the company’s ability to generate profits from its operations. The operating profit per share experienced a gradual decline during this period, but the share price increased at a faster rate, driving the P/OP ratio higher.

Recent Decline (Mar 31, 2024 – Dec 31, 2025)

Beginning in March 2024, the P/OP ratio began a downward trend, decreasing from 26.82 to 22.90 by December 2025. While there were some fluctuations, the overall direction is downward. This decline coincides with a decrease in the share price and a relatively stable operating profit per share, suggesting a potential recalibration of market expectations. The ratio experienced a significant drop to 16.03 in March 2025 before partially recovering.

The operating profit per share exhibited a consistent, albeit gradual, decline throughout the entire analyzed period, from 82.78 to 33.84. However, the share price movements were more pronounced, driving the overall changes observed in the P/OP ratio. The most significant increases in the P/OP ratio occurred when share price appreciation outpaced the decline in operating profit per share.

In summary, the P/OP ratio reflects a dynamic relationship between the company’s share price and its operating profitability. The observed trends suggest periods of strong investor optimism followed by a more recent period of adjustment, potentially influenced by evolving market conditions and expectations.

The price-to-sales ratio for the analyzed period demonstrates considerable fluctuation. Initially, the ratio exhibited an increasing trend from March 31, 2022, to December 31, 2022, followed by a period of decline and subsequent recovery. A detailed examination reveals specific patterns and shifts in this valuation metric.

Initial Increasing Trend (Mar 31, 2022 – Dec 31, 2022)

The price-to-sales ratio increased from 4.40 in March 2022 to 7.01 in December 2022. This suggests a growing investor willingness to pay a premium for each dollar of sales during this period. The most significant increase occurred between September 2022 and December 2022, moving from 5.87 to 7.01.

Subsequent Decline (Jan 1, 2023 – Dec 31, 2023)

Following the peak in December 2022, the ratio experienced a decline, reaching 7.84 in March 2023, then increasing to 8.93 in June 2023 before falling to 7.84 in December 2023. This indicates a potential shift in market sentiment or a reassessment of the company’s growth prospects relative to its share price.

Further Reduction and Stabilization (Jan 1, 2024 – Dec 31, 2024)

The ratio continued its downward trajectory in the first half of 2024, reaching a low of 5.52 in December 2024. This represents a substantial decrease from the peak observed in late 2022. The ratio decreased from 7.89 in March 2024 to 5.52 in December 2024.

Recent Fluctuations (Jan 1, 2025 – Jun 30, 2025)

From December 2024 through June 2025, the ratio showed some recovery, increasing from 4.36 to 4.83 in September 2025, and then to 5.71 in December 2025. This suggests a potential stabilization or renewed investor interest, although the ratio remains below the levels seen in 2022 and early 2023.

Sales per Share Trend

Sales per share generally increased over the period, from 150.28 in March 2022 to 135.67 in December 2025. However, the rate of increase slowed down in later periods. The P/S ratio movements are not directly correlated with the sales per share increases, suggesting that share price fluctuations have a more significant impact on the ratio.

In summary, the price-to-sales ratio experienced a period of growth followed by a notable decline and a recent, modest recovery. These fluctuations suggest changing market perceptions of the company’s valuation relative to its sales performance. The ratio’s behavior warrants continued monitoring to assess the sustainability of any emerging trends.

The price-to-book value (P/BV) ratio for the analyzed period demonstrates considerable fluctuation. Initially, the ratio exhibited a decline from 3.65 in March 2022 to a low of 3.21 in June 2022, followed by a moderate increase to 3.75 by September 2022. The ratio remained relatively stable through December 2022, registering 3.77.

Trend Analysis (2022-2023)

A slight downward trend was observed in the first half of 2023, with the P/BV ratio decreasing from 3.52 in March to 3.49 in June. The ratio then experienced a gradual increase throughout the remainder of 2023, peaking at 3.96 in December. This suggests a strengthening of investor confidence relative to the company’s book value during that period.

A significant increase occurred in the first half of 2024, with the P/BV ratio rising to 4.27 in June. However, this was followed by a substantial and consistent decline throughout the remainder of the analyzed period. The ratio decreased to 3.14 by September 2024, and continued its downward trajectory, reaching 2.09 in March 2025. A slight recovery was noted in June 2025 (1.98 to 2.22 in September), but the ratio increased again to 2.62 by December 2025.

Book Value Per Share (BVPS) Correlation

The book value per share consistently increased throughout the period, moving from US$181.30 in March 2022 to US$295.66 in December 2025. The declining P/BV ratio, particularly from mid-2024 onwards, occurred *despite* this consistent growth in BVPS, indicating that the share price did not keep pace with the increasing book value. This divergence suggests a potential shift in market perception or other factors influencing the stock’s valuation.

The most pronounced change observed was the significant decrease in the P/BV ratio during 2024 and early 2025. This indicates a substantial re-evaluation of the company’s stock relative to its net asset value. The final value of 2.62 in December 2025, while representing a partial recovery from the low of 2.09, remains considerably lower than the values observed in the earlier part of the analyzed period.

Volatility

The P/BV ratio exhibited considerable volatility throughout the period, with fluctuations exceeding 1 full ratio point between consecutive quarters. This suggests that the market valuation of the company’s book value is subject to change based on various factors, and is not consistently stable.